129 related articles for article (PubMed ID: 17213726)
21. [A study of the oncolytic effect of a newly designed CDDP system on an experimental animal model with carcinomatous ascites].
Shindoh T; Matsuura N; Sugitachi A; Saitoh K
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2195-8. PubMed ID: 12484035
[TBL] [Abstract][Full Text] [Related]
22. [In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites].
Geng M; Ma T; YeE ZB; Ji YB; Lou GY; Xi WQ; Jiang JS; Xia HQ; Li H
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):460-3. PubMed ID: 17152496
[TBL] [Abstract][Full Text] [Related]
23. Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells.
Kobayashi T; Fujii T; Jo Y; Kinugawa K; Fujisawa M
J Urol; 2004 May; 171(5):1929-33. PubMed ID: 15076314
[TBL] [Abstract][Full Text] [Related]
24. C6 cells cross-resistant to cisplatin and radiation.
Poppenborg H; Münstermann G; Knüpfer MM; Hotfilder M; Wolff JE
Anticancer Res; 1997; 17(3C):2073-7. PubMed ID: 9216666
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of CDDP administration into the body cavity].
Kikuchi K; Fujisaki M; Tamura T; Takahashi R; Kurihara E; Takada Y; Suito T; Uematsu Y
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3253-8. PubMed ID: 3688890
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency.
Martelli L; Ragazzi E; Di Mario F; Basato M; Martelli M
Anticancer Res; 2009 Oct; 29(10):3931-7. PubMed ID: 19846931
[TBL] [Abstract][Full Text] [Related]
29. [Multi-drug chemotherapy for patients with peritonitis carcinomatosa associated with ascites].
Hirono M; Yoshihara T; Hayashi Y; Suzuki M; Majima H
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):672-8. PubMed ID: 2351859
[TBL] [Abstract][Full Text] [Related]
30. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
31. [A novel Cisplatin delivery system for malignant ascites-bearing mice-a basic experimentation].
Itabashi T; Sugitachi A; Kimura Y; Ikeda M; Kumagai M; Matsuo T; Fujii H; Nishizuka S; Otsuka K; Koeda K; Sasaki A; Wakabayashi G
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2081-3. PubMed ID: 22202290
[TBL] [Abstract][Full Text] [Related]
32. [Intraperitoneal cisplatinum chemotherapy in patients with carcinomatous peritonitis due to colorectal scirrhous cancer--case report].
Morimoto T; Furukawa J; Katsumoto Y; Shingai T; Azama T; Yoshioka S; Nakaguchi K; Okajima S; Sue F; Yoshihara W
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1925-8. PubMed ID: 10560427
[TBL] [Abstract][Full Text] [Related]
33. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
[TBL] [Abstract][Full Text] [Related]
35. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
[TBL] [Abstract][Full Text] [Related]
36. Experimental study on paratumoral injection of cisplatin-loaded microspheres for gastric cancer.
Narita K; Ikuta H; Hamabe Y; Kuroda Y
Kobe J Med Sci; 1999 Oct; 45(5):229-43. PubMed ID: 10853189
[TBL] [Abstract][Full Text] [Related]
37. [The third report from Sapporo Tsukisamu Hospital--chemotherapy for patients with advanced gastric cancer (peritoneal dissemination, peritonitis carcinomatosa)].
Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1405-11. PubMed ID: 17876138
[TBL] [Abstract][Full Text] [Related]
38. [Chemosensitivity test for gastric carcinoma].
Kubota T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490
[TBL] [Abstract][Full Text] [Related]
39. [Colony assay for clinical application].
Ichihashi H; Sako T; Akiyama S
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1560-5. PubMed ID: 3927845
[TBL] [Abstract][Full Text] [Related]
40. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
